⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Popular Peptides

Cagri (10 vials)

Third-Party Tested
Quantity
Price
$300.00
Select Size
Quick Quantity Selection

Email when stock available

In stock – Ships same day

SSL Secured Secure Checkout Guaranteed Delivery Third-Party Tested

Compound Information

Technical specifications

Molecular Profile

What Is Cagri (10 vials)?

Type Long-acting Amylin Receptor Agonist
CAS Number 2134203-57-0
Molecular Weight 4408.258 g/mol
Molecular Weight (Cu) N/A
Amino Acids 37 Amino Acids (Modified Analog)
Sequence Modified synthetic peptide analog of human amylin
Formula $C_{184}H_{296}N_{52}O_{57}$
Storage Requirements

Stability Information

Lyophilized powder; keep sealed, dry, and protected from light.Store at a stable temperature and minimize warming/cooling cycles.After reconstitution, avoid repeated freeze–thaw cycles.
Lyophilized storage
Lyophilized Powder –20°C
Reconstituted storage
Reconstituted 2-8°C

About Cagri (10 vials)

Cagrilintide is a lyophilized synthetic peptide analog developed for scientific and laboratory research applications. It functions as a long-acting amylin receptor agonist, structurally modified to enhance stability and extend its biological activity profile in vivo. Cagrilintide has been studied for its synergistic effects when combined with GLP-1 receptor agonists, particularly in the context of appetite regulation, body weight management, and metabolic signaling. Its mechanism involves modulation of satiety-related pathways and delayed gastric emptying, making it a compound of interest in obesity and metabolic research.

Mechanism of Action

The mechanism involves Cagrilintide acting as a potent agonist for amylin receptors in the area postrema of the hindbrain. By activating these receptors, it triggers central satiety signals that reduce food intake. Furthermore, it slows gastric emptying, which contributes to a prolonged feeling of fullness. When used in research alongside GLP-1 agonists, it targets complementary pathways in the hypothalamus, investigating a multi-receptor approach to energy homeostasis and glucose metabolism.

What Research Has Shown

Metabolic Research
98 Purity Percentage (HPLC Verified)
Synergistic Weight Management Signaling
Cagrilintide + GLP-1 Analog 94.5%
Single Receptor Agonist 62.0%
Trial details: Preclinical studies in obesity and appetite signaling models focusing on delayed gastric emptying and metabolic regulation.
Satiety Results

Appetite Regulation & Energy Homeostasis

Findings from amylin and GLP-1 receptor interaction studies

92% Satiety Signaling Enhanced Hypothalamic Activation
85% Gastric Emptying Significantly Delayed Rate
Note: Results highlight the compound's potential in obesity and metabolic research.

Research Highlights

Product Specifications

Research Studies

Frequently Asked Questions

What is the primary biological function of Cagrilintide?

It functions as a long-acting amylin receptor agonist, modulating satiety-related pathways and energy homeostasis.

Is it often studied alone or in combination?

While studied alone, it is a significant compound of interest for its synergistic effects when combined with GLP-1 receptor agonists in metabolic research.

Molecule illustration

Related Products

TESA 10MG (10 vials)

Copper Peptides

From

$370.00

KLOW (10 vials)

Copper Peptides

From

Original price was: $500.00.Current price is: $470.00.

GLOW (10Vials)

Copper Peptides

From

$389.99

Select options This product has multiple variants. The options may be chosen on the product page
From

$30.00